It all points to solid progress, increasing revenues and potentially beating guidance
- secured an additional micro fab client to join the two initial 'anchor clients' with potential to transition to manufacturing in approx 12 months (similar turnaround time to abiomed) This particular company/client sounds quite large.
- advanced negotiations to secure a long term supply agreements for anchor and software worth potentially US$2m - US$3m per annum. Seeking to finalise terms by years end...
Lots to look forward to
SE1 Price at posting:
33.5¢ Sentiment: Buy Disclosure: Held